“Multiple myeloma red flag”的搜索结果，显示 41-50 项，共有 10999 项

1. 血液科- 临床试验- 妙佑医疗国际

   Alternate Doses And Dosing Schedules Of Belantamab Mafodotin For The Treatment Of Triple-Class Recurrent And/or Refractory Multiple Myeloma. Jacksonville ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This study is researching an experimental drug called linvoseltamab in combination with other drugs for the treatment of a blood cancer called multiple myeloma.

3. 神经科- 临床试验- 妙佑医疗国际

   ... multiple myeloma. Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Alternate Doses And Dosing Schedules Of Belantamab Mafodotin For The Treatment Of Triple-Class Recurrent And/or Refractory Multiple Myeloma. Jacksonville ...

5. 血液科- 临床试验- 妙佑医疗国际

   This clinical trial evaluates the impact of preexisting and therapy-emergent germline and somatic variants on cytopenia in patients with multiple myeloma or ...

6. 血液科- 临床试验- 妙佑医疗国际

   This clinical trial evaluates the impact of preexisting and therapy-emergent germline and somatic variants on cytopenia in patients with multiple myeloma or ...

7. 多发性骨髓瘤- 医生与科室- 妙佑医疗国际

   Thomas E. Witzig, M.D.. Internist; Oncologist; Hematologist. Rochester, MN. 擅长领域：. Multiple myeloma, Non- ...

8. 神经科- 临床试验- 妙佑医疗国际

   ... multiple myeloma. Also eligible are (11) up to 6 donors with triple negative breast cancer and (12) up to 6 donors with colorectal cancer who have no ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   A Study To Evaluate APG2575 Combined With Novel Therapeutic Regimens To Treat Subjects With Relapsed Or Refractory Multiple Myeloma And Immunoglobulin Light ...

10. Mayo Clinic Cancer Physician Update - November 2025

    Page 1.